Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Frediani

Showing results (271-280 of 336) with videos related to

Pageof 34
Sort By:
Rheumatology International|April 29, 2017
The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society for RheumatologyAlberto Migliore, Carlo Alberto Scirè, Loreto Carmona, et al.
Clinical and Experimental Rheumatology|August 31, 2023
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDsLaura Scagnellato, Antonio Collesei, Andrea Doria, et al.
Frontiers in Medicine|June 16, 2023
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs)Antonio Vitale, Valeria Caggiano, Isabel Silva, et al.
Rheumatology (Oxford, England)|January 25, 2022
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's diseasePiero Ruscitti, Valentina Natoli, Alessandro Consolaro, et al.
Joint Bone Spine|August 7, 2020
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEAFlorenzo Iannone, Ennio G Favalli, Roberto Caporali, et al.
Journal of Clinical Medicine|July 27, 2022
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational StudySalvatore D'Angelo, Enrico Tirri, Angela Maria Giardino, et al.
Ophthalmology and Therapy|April 2, 2024
Ocular Manifestations in Juvenile Behçet's Disease: A Registry-Based Analysis from the AIDA NetworkCarla Gaggiano, Abdurrahman Tufan, Silvana Guerriero, et al.
Clinical and Experimental Rheumatology|December 18, 2018
Radiologist-rheumatologist multidisciplinary approach in the management of axial spondyloarthritis: a Delphi consensus statementAntonio Marchesoni, Salvatore D'Angelo, Michele Anzidei, et al.
Ophthalmology and Therapy|May 11, 2023
Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis RegistryAntonio Vitale, Francesca Della Casa, Silvana Guerriero, et al.
Rheumatology Advances in Practice|March 22, 2024
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaireElena Treppo, Miriam Isola, Maria De Martino, et al.
Pageof 34

Showing results (271-280 of 336) with videos related to

Sort By:
Pageof 34
Rheumatology International|April 29, 2017
The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society for RheumatologyAlberto Migliore, Carlo Alberto Scirè, Loreto Carmona, et al.
Clinical and Experimental Rheumatology|August 31, 2023
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDsLaura Scagnellato, Antonio Collesei, Andrea Doria, et al.
Frontiers in Medicine|June 16, 2023
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs)Antonio Vitale, Valeria Caggiano, Isabel Silva, et al.
Rheumatology (Oxford, England)|January 25, 2022
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's diseasePiero Ruscitti, Valentina Natoli, Alessandro Consolaro, et al.
Joint Bone Spine|August 7, 2020
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEAFlorenzo Iannone, Ennio G Favalli, Roberto Caporali, et al.
Journal of Clinical Medicine|July 27, 2022
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational StudySalvatore D'Angelo, Enrico Tirri, Angela Maria Giardino, et al.
Ophthalmology and Therapy|April 2, 2024
Ocular Manifestations in Juvenile Behçet's Disease: A Registry-Based Analysis from the AIDA NetworkCarla Gaggiano, Abdurrahman Tufan, Silvana Guerriero, et al.
Clinical and Experimental Rheumatology|December 18, 2018
Radiologist-rheumatologist multidisciplinary approach in the management of axial spondyloarthritis: a Delphi consensus statementAntonio Marchesoni, Salvatore D'Angelo, Michele Anzidei, et al.
Ophthalmology and Therapy|May 11, 2023
Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis RegistryAntonio Vitale, Francesca Della Casa, Silvana Guerriero, et al.
Rheumatology Advances in Practice|March 22, 2024
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaireElena Treppo, Miriam Isola, Maria De Martino, et al.
Pageof 34